(Reuters) – Atrium Innovations Inc, a maker of dietary supplements, said a group of investors, including European private equity firm Permira funds, would acquire the company for about C$1.1 billion ($1 billion), including debt.
Atrium shareholders will receive C$24.00 in cash per share, a nearly 23 percent premium to the stock’s Thursday close on the Toronto Stock Exchange.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.